WVE
NASDAQ
$5.73
Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes and produces new stereopure oligonucleotides through PRISM, a drug discovery and development platform. The company is headquartered in Singapore.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $21.94 (+282.90%)
Market Cap
$1.14B
Revenue 5Y CAGR
+35.16%
Free Cash Flow Yield
-16.27%
Beta (5Y)
1.46
Price Chart
Valuation
Market Cap$1.14B
P/S16.43
P/B2.31
Profitability
Total Revenue (TTM)$72M
Gross Profit (TTM)-$118M
EBITDA-$193M
Profit Margin-68.2%
Operating Margin-81.8%
EPS-$1.08
Financial Health
Free Cash Flow Yield-16.27%
Growth & Risk
EPS 5Y CAGR-19.81%
Revenue 5Y CAGR+35.16%
FCF 5Y CAGR+6.51%
Beta (5Y)1.46
Sharpe Ratio0.35